单位:[1]Dept of Pulmonary and Critical Care Medicine, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[2]Institute of Respiratory Medicine, ChineseAcademy of Medical Science, Beijing, China[3]Institute of Clinical Medical Sciences, China-Japan FriendshipHospital, Beijing, China[4]Dept of Respiratory Medicine, Capital Medical University, Beijing, China[5]TsinghuaUniversity-Peking University Joint Center for Life Sciences, Beijing, China
According to the Third International Consensus Definition for Sepsis and Septic Shock, sepsis is a life-threatening organ dysfunction resulting from dysregulated host responses to infection. Epidemiological data about sepsis from the 2017 Global Burden of Diseases, Injuries and Risk Factor Study showed that the global burden of sepsis was greater than previously estimated. Bacteria have been shown to be the predominant pathogen of sepsis among patients with pathogens detected, while sepsis caused by viruses is underdiagnosed worldwide. The coronavirus disease that emerged in 2019 in China and now in many other countries has brought viral sepsis back into the vision of physicians and researchers worldwide. Although the current understanding of the pathophysiology of sepsis has improved, the differences between viral and bacterial sepsis at the level of pathophysiology are not well understood. Diagnosis methods that can broadly differentiate between bacterial and viral sepsis at the initial stage after the development of sepsis are limited. New treatments that can be applied at clinics for sepsis are scarce and this situation is not consistent with the growing understanding of pathophysiology. This review aims to give a brief summary of current knowledge of the epidemiology, pathophysiology, diagnosis and treatment of viral sepsis.
基金:
Special Project for Emergency of the Ministry of Science and Technology [2020YFC0841300]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [CIFMS 2018-I2M-1-003]; National Science Grant for Distinguished Young Scholars [81425001/H0104]; National Key Research and Development Program of China [2018YFC1200102]; Beijing Science and Technology Project [Z19110700660000]
第一作者单位:[1]Dept of Pulmonary and Critical Care Medicine, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[2]Institute of Respiratory Medicine, ChineseAcademy of Medical Science, Beijing, China[3]Institute of Clinical Medical Sciences, China-Japan FriendshipHospital, Beijing, China
通讯作者:
通讯机构:[1]Dept of Pulmonary and Critical Care Medicine, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[2]Institute of Respiratory Medicine, ChineseAcademy of Medical Science, Beijing, China[4]Dept of Respiratory Medicine, Capital Medical University, Beijing, China[5]TsinghuaUniversity-Peking University Joint Center for Life Sciences, Beijing, China[*1]Dept of Pulmonary and Critical Care Medicine, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, 2 East Yinghua Street, Beijing, 100029, China